Last Posted: Nov 14, 2019
- Effects of Pharmacogenetic Screening for CYP2D6 Among Elderly Starting Therapy With Nortriptyline or Venlafaxine: A Pragmatic Randomized Controlled Trial (CYSCE Trial).
van der Schans Jurjen et al. Journal of clinical psychopharmacology 2019 Oct - Hereditary angioedema in children: a review and update.
Pancholy Neha et al. Current opinion in pediatrics 2019 Dec 31(6) 863-868 - Bipolar multiplex families have an increased burden of common risk variants for psychiatric disorders
F Till et al, Molecular Psychiatry, November 11, 2019 - The benefits of genetic addiction risk score (GARS™) and pro-dopamine regulation in combating suicide in the American Indian population.
Blum Kenneth et al. Journal of systems and integrative neuroscience 2018 Sep 4 - Does preventive oophorectomy increase the risk of depression in BRCA mutation carriers?
Kotsopoulos Joanne et al. Menopause (New York, N.Y.) 2019 Oct - Personalise antidepressant treatment for unipolar depression combining individual choices, risks and big data (PETRUSHKA): rationale and protocol.
Tomlinson Anneka et al. Evidence-based mental health 2019 Oct - Prediction of Sex-Specific Suicide Risk Using Machine Learning and Single-Payer Health Care Registry Data From Denmark.
Gradus Jaimie L et al. JAMA psychiatry 2019 Oct - Vision of the Future of Medical Science
Francis Collins, Time, October 25, 2019 - Angelina Jolie: Medical Advances in Women's Health Are Important. But They're Only Part of the Picture
A Jolie, Time, October 24, 2019 - A pharmacogenetic risk score for the evaluation of major depression severity under treatment with antidepressants.
Kanders Sofia H et al. Drug development research 2019 Oct
.png)
No hay comentarios:
Publicar un comentario